1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GAMIDA CELL LTD

Gamida Cell Ltd

XNAS: GMDAQ

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Gamida Cell Ltd is on 27 Mar 2025 for the purpose of Gamida Cell Ltd Annual Report for 2024 See details


Insider Trading disclosures for Gamida Cell Ltd

The latest disclosure was made by Ivan Borrello M. in Gamida Cell Ltd where a trade of 200,000 Ordinary Shares done was reported to US exchanges on Jan. 31, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Ivan Borrello M. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 200,000 232,300 - 0 Ordinary Shares
Joshua Patterson GENERAL COUNSEL Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 480,319 855,461 - 0 Ordinary Shares
Simantov Ronit CMO & CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 480,319 655,896 - 0 Ordinary Shares
Thomas Wills Stephen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 200,000 256,177 - 0 Ordinary Shares
Kenneth Moch I. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 200,000 232,300 - 0 Ordinary Shares
Julian Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 200,000 423,750 - 0 Ordinary Shares
Tomasello Shawn Cline Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 200,000 241,977 - 0 Ordinary Shares
Korfin Michele COO/CHIEF COMMERCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 480,319 702,981 - 0 Ordinary Shares
Jeremy Blank Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2023 4,000 4,000 - 0 Ordinary Shares
Jeremy Blank Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2023 19,000 19,000 - - Share Option (Right to Buy)
Shawn Cline Tomasello Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Mar 2023 17,000 17,000 - - Share Option (Right to Buy)
Anat Cohen-Dayag Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 28,300 32,300 - 0 Ordinary Shares
Kenneth I. Moch Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 28,300 32,300 - 0 Ordinary Shares
Anat Cohen-Dayag Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 56,600 56,600 - - Share Option (Right to Buy)
Stephen Thomas Wills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 56,600 56,600 - - Share Option (Right to Buy)
Stephen Thomas Wills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 28,300 28,300 - - Share Option (Right to Buy)
Stephen Thomas Wills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 28,300 41,977 - 0 Ordinary Shares
Stephen Thomas Wills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 14,200 56,177 - 0 Ordinary Shares
Robert I. Blum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 28,300 82,300 - 0 Ordinary Shares
Robert I. Blum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 28,300 28,300 - - Share Option (Right to Buy)
Robert I. Blum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 56,600 56,600 - - Share Option (Right to Buy)
Robert I. Blum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 14,200 96,500 - 0 Ordinary Shares
Julian Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 28,300 223,750 - 0 Ordinary Shares
Shai Lankry Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 56,480 145,425 - 0 Ordinary Shares
Shai Lankry Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 113,000 113,000 - - Employee Share Option (Right to Buy)
Shawn Cline Tomasello Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 56,600 56,600 - - Share Option (Right to Buy)
Shawn Cline Tomasello Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 28,300 41,977 - 0 Ordinary Shares
Ronit Simantov CMO & Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 58,100 175,577 - 0 Ordinary Shares
Ronit Simantov CMO & Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 116,340 116,340 - - Employee Share Option (Right to Buy)
Michele Korfin COO/Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 186,150 186,150 - - Employee Share Option (Right to Buy)
Michele Korfin COO/Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 92,990 222,662 - 0 Ordinary Shares
Joshua Patterson General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 63,000 144,000 - 0 Ordinary Shares
Joshua Patterson General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 125,860 125,860 - - Employee Share Option (Right to Buy)
Naama Halevi Davidov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 28,300 32,300 - 0 Ordinary Shares
Naama Halevi Davidov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 56,600 56,600 - - Share Option (Right to Buy)
Ivan M. Borrello Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 28,300 32,300 - 0 Ordinary Shares
Ivan M. Borrello Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 56,600 56,600 - - Share Option (Right to Buy)
Kenneth I. Moch Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 56,600 56,600 - - Share Option (Right to Buy)
Julian Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 56,600 56,600 - - Share Option (Right to Buy)
Julian Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2022 2,000 195,450 - 0 Ordinary Shares
Julian Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2022 9,500 9,500 - - Share Option (Right to Buy)
Kenneth I. Moch Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2022 9,500 9,500 - - Share Option (Right to Buy)
Kenneth I. Moch Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2022 2,000 4,000 - 0 Ordinary Shares
Robert I. Blum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2022 2,000 54,000 - 0 Ordinary Shares
Robert I. Blum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2022 12,500 12,500 - - Share Option (Right to Buy)
Stephen Thomas Wills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2022 9,500 9,500 - - Share Option (Right to Buy)
Stephen Thomas Wills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2022 2,000 13,677 - 0 Ordinary Shares
Shawn Cline Tomasello Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2022 2,000 13,677 - 0 Ordinary Shares
Shawn Cline Tomasello Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2022 9,500 9,500 - - Share Option (Right to Buy)
Robert I. Blum Director Purchase of securities on an exchange or from another person at price $ 1.55 per share. 30 Sep 2022 50,000 52,000 - 1.6 77,500 Ordinary Shares
Stephen Thomas Wills Director Purchase of securities on an exchange or from another person at price $ 1.55 per share. 30 Sep 2022 9,677 11,677 - 1.5 14,999 Ordinary Shares
Abigail L. Jenkins Director, President and CEO Purchase of securities on an exchange or from another person at price $ 1.55 per share. 30 Sep 2022 16,129 266,129 - 1.6 25,000 Ordinary Shares
Shawn Cline Tomasello Director Purchase of securities on an exchange or from another person at price $ 1.55 per share. 30 Sep 2022 9,677 11,677 - 1.5 14,999 Ordinary Shares
Abigail L. Jenkins Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2022 250,000 250,000 - 0 Ordinary Shares
Abigail L. Jenkins Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2022 1,000,000 1,000,000 - - Stock Option (Right to Buy)
Julian Adams Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2022 48,500 124,650 - 0 Ordinary Shares
Julian Adams Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2022 291,100 291,100 - - Employee Share Option (Right to Buy)
Julian Adams Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2022 68,800 193,450 - 0 Ordinary Shares
Ivan M. Borrello Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 4,000 4,000 - 0 Ordinary Shares
Ivan M. Borrello Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,000 19,000 - - Stock Option (Right to Buy)
Anat Cohen-Dayag Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 19,000 19,000 - - Stock Option (Right to Buy)
Anat Cohen-Dayag Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 4,000 4,000 - 0 Ordinary Shares
Shai Lankry Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 92,400 92,400 - - Employee Share Option (Right to Buy)
Shai Lankry Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 43,000 88,945 - 0 Ordinary Shares
Michele Korfin COO/Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 125,000 125,000 - - Employee Share Option (Right to Buy)
Michele Korfin COO/Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 63,800 129,672 - 0 Ordinary Shares
Joshua Patterson General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 51,000 81,000 - 0 Ordinary Shares
Joshua Patterson General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2022 77,900 77,900 - - Employee Share Option (Right to Buy)
Naama Halevi Davidov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2022 4,000 4,000 - 0 Ordinary Shares
Naama Halevi Davidov Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2022 19,000 19,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters